Medicine

Niacin, food intake as well as cardiovascular effects

.Attributes Medicine, Posted online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, meals ...

Opportunities and challenges for patient-reported outcome evaluation in multimorbidity research study and also strategy

.Contending rate of interests.S.E.H. acquires funding coming from the National Principle of Health a...

Hibernation scientific research harnessed to handle obesity and customize metabolic rate

.Attribute Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy understan...

CAR- T and also cellular gene treatments are actually too costly

.Mother Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of...

The that genomics system of benefit fair implementation of human genomics for global health and wellness

.The magazine of the first draft of the individual genome pattern in 20011 was followed due to the a...

A time-stratified, case\u00e2 $ \"crossover study of heat energy visibility and perinatal death from 16 healthcare facilities in sub-Saharan Africa

.One of 138,015 hospital-based individual childbirths in 4 sub-Saharan African countries, our compan...

Advancing global antibiotic research study, progression and also accessibility #.\n\nMurray, C. J. L. et al. International burden of microbial antimicrobial resistance in 2019: a methodical analysis. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of specific devotions and action in the feedback to antimicrobial protection. Worldwide Leaders Group on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Globe Health And Wellness Company. WHO publishes checklist of microorganisms for which brand-new prescription antibiotics are actually quickly needed. Globe Health and wellness Institution https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). World Health And Wellness Organization. That bacterial priority virus listing, 2024: microbial virus of public health usefulness to assist research, progression and methods to avoid and also control antimicrobial protection. Globe Wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entry. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Organization. 2023 anti-bacterial brokers in clinical as well as preclinical development: a summary as well as review. Globe Wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Customer review. May 19, 2016 \u00e2 $\" Tackling drug-resistant contaminations worldwide: ultimate record as well as recommendations. Assessment on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outcomes: files as well as briefing. Drive abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Breaking through the wall: an ask for concerted action on anti-biotics trial and error. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Brief 51: Just how can the EU help lasting advancement and also access to efficient prescription antibiotics? policy alternatives for existing and also new medicines. European Observatory on Health Units as well as Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic make use of and also resistance\u00e2 $\" confirming the evident. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Health And Wellness Company. 2021 Informed category. WHO accessibility, view, book, category of prescription antibiotics for evaluation and also tracking of utilization. World Health and wellness Association https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Facility for Health Condition Deterrence as well as Management. Antimicrobial protection intendeds: how can we reach all of them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Planet Wellness Organization. Shortage of development set to weaken antibiotic performance as well as wellness increases. Planet Health and wellness Company https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Just how antimicrobial protection is actually connected to weather improvement: an overview of 2 intertwined worldwide problems. Int. J. Environ. Res. Hygienics 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial diseases: we need to have urgent action and expenditure that pay attention to the weakest hyperlink. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Institution. Immunization insurance coverage. World Health and wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Contamination deterrence and control in low-resource environments: the need for the nearby, the contextual and also the pragmatic. Infect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Challenges of applying antimicrobial stewardship resources in reduced to middle revenue countries (LMICs). Corrupt. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A short past history of the antibiotic time: courses learned as well as problems for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Individual get access to in 14 high-income countries to new antibacterials accepted due to the United States Fda, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Gadget Agency, or Health Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Wellness Organization. 2021 anti-bacterial brokers in scientific as well as preclinical progression: a review and also analysis. Globe Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the economics must sustain the science. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of advancement in anti-bacterial therapies. Medical Development Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Examining clinician utilization of next-generation antibiotics against insusceptible Gram-negative contaminations in USA hospitals: a retrospective cohort study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of development in antibacterial therapeutics. Biotechnology Innovation Association https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A step-by-step assessment as well as essential analysis of incentive tactics for revelation and also growth of novel antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth Emergency Preparedness as well as Action Authority. Experimentation of medical countermeasures. International Percentage https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Compensation. Pre-draft proposition for an European collaboration under Horizon Europe One Health And Wellness Antimicrobial Resistance. International Percentage https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Prescription Antibiotic Research and Development Relationship. Entasis Therapeutics as well as the Global Antibiotic Investigation &amp Progression Partnership to create a new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of business- as well as non-industry-sponsored professional trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health Organization. Amount of scientific test registrations through area, illness, stage of development, grow older and sex of trial individuals (1999\u00e2 $ \"2022). Planet Health and wellness Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Anti-biotic Research and Development Partnership. NeoSept1: a research study to identify the position of existing and also new prescription antibiotics combos to treat newborns that are in medical facility along with serious sepsis. ISRCTN pc registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Company of Canada. Government of Canada brings in essential assets to fight antimicrobial resistance (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Anti-biotic Experimentation Alliance. Asia government funding assists GARDP\u00e2 $ s initiatives to counter antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Foundation. Novo Nordisk Structure companions with CARB-X to fight drug-resistant infections. novo nordisk groundwork https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Wellness and Digital Manager Agency. Research on carrying AMR medical countermeasures to the marketplace. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Predicting the ideal measurements of global pull incentives for anti-bacterial medicines. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entry benefit for the development of brand new antibiotics. Harvard Kennedy University https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Industry rewards and antibiotic resistance: an overview to the antibiotic susceptibility bonus. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An eager USG accelerated devotion for subscription-based purchasing of unfamiliar antimicrobials and its own anticipated roi. Facility for Global Development https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 investments in brand new prescription antibiotics would repay \u00e2 $\" for every person. Office of Health and wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up battle versus life-threatening infections following effective world-first captain. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Percentage. Reform of the EU pharmaceutical legalisation. European Percentage https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Reimbursement versions to tackle market failures for antimicrobials: techniques absorbed France, Germany, Sweden, the United Kingdom, and also the USA. Wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers as well as Organizations. From protection to resilience: what could the future antibiotic pipeline seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Center &amp World Health And Wellness Association. Incentivising the growth of brand-new anti-bacterial procedures: 2023 progress report by the International AMR R&ampD Hub and also That. International AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Vocalist, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK membership style for anti-biotics taken into consideration effective? Lancet Micro organism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimulations for the progression and keeping on the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, local, and nationwide sources of youngster mortality in 2000\u00e2 $ \"13, along with estimates to update post-2015 priorities: an improved organized evaluation. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et al. Antibacterial drug lacks from 2001 to 2013: ramifications for medical application. Clin. Affect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et cetera. The French reporting unit for medicine scarcities: explanation and also patterns coming from 2012 to 2018: an empirical retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et al. Examination of that antibiotic consumption and accessibility aim ats in 76 countries, 2000\u00e2 $ \"15: a study of pharmaceutical purchases data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Battling the counterfeits: addressing second-rate as well as falsified medicines. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving less complicated to acquire prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrican Culture for Research Laboratory Medication. Plan brief and infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic intake for individual use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Medication. Infect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial consumption: analysis of core stockrooms materials to in-patient care health and wellness locations from 2017 to 2019 in Uganda. Trop. Medication. Affect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Varieties in the usage of antimicrobial medicines in the International location, 2014\u00e2 $ \"2018: lookings for as well as ramifications from ESAC-Net as well as WHO Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et al. Medicine lack: triggers, effect, and also reduction approaches. Front. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Client accessibility in 14 high-income countries to brand new antibacterials permitted due to the US Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals and also Medical Instruments Firm, or even Wellness Canada, 2010\u00e2 $ \"2020. Clin. Infect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Lost antibiotics: a follow-up supply research study in Europe, the U.S.A., Canada and also Australia. Int. J. Antimicrob. Representatives 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness development for international wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Industry Partnership. The 2023 AMR Sector Partnership improvement survey: manufacturing as well as the setting. amr Sector Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Foray, D. &amp Gaule, P. Can health care items be cultivated on a non-profit manner? Discovering product growth partnerships for forgotten illness. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the global public enthusiasm. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Health Condition Control and also Prevention. Africa CDC directs daring move to get Africa\u00e2 $ s wellness future by creating a fifty billion dollar clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Blood, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Negotiating public-health trademark licensing arrangements to increase accessibility to wellness innovations: an insider\u00e2 $ s account. BMJ Glob. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New business designs for trial and error with cost demands are needed to attain fair pricing of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator. Stewardship as well as accessibility. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Global Antibiotic Trial And Error Collaboration. Shinogi, GARDP and also CHAI announce landmark permit as well as partnership deals to deal with bacterial diseases next to increasing accessibility to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Sector Partnership. Leaving behind the laboratory: tracking the decrease in AMR R&ampD specialists. amr Sector Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 contact us to activity on antimicrobial protection. G7G20 Documents Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). Worldwide Union on Growing Old &amp Transmittable Ailments Society of The United States. 2024 AMR preparedness index progress report. Gauging federal government action on AMR plan. International Coalition on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items as well as Horticulture Organization of the United Nations, United Nations Environment Program, Globe Wellness Organization &amp. Globe Organisation for Creature Wellness. International data bank for tracking antimicrobial protection (AMR): nation self-assessment survey (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the glo...

Integrating liver endpoints in medical trials of cardiovascular as well as renal ailment

.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of...

FALSE:: MISTAKE: UNSUPPORTED ENCODING...

Artificial knowledge led assessment for cardiomyopathies in an obstetric population: a practical randomized scientific test

.Test design and oversightThe Testing for PEripartum Cardiomyopathies with Artificial Intelligence i...